Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

Letter/Comment
The AHRMM LUC members submitted public comments and recommendations at the FDA's November 2020 meeting related to the need to include the UDI in the…
Guides/Reports
Building UDI into Longitudinal Data for Medical Device Evaluation (BUILD) Point of Care Capture of UDI for Implantable Devices final summary report…
On-Demand Educational Webinars
Consider how the four emerging themes on purchased services and their leading practices can deliver improved margins.
e-Learning
Updated for 2020! Begin your studies of the Supply Chain Management and Finance relationship portion within the CMRP examination with a new…
On-Demand Educational Webinars
Health care supply chain leaders discuss methods to reduce the impact of demand surges and supply shortages due to unexpected events. A three-part…
On-Demand Educational Webinars
In the first half of the webinar, we will explore the Hospital PMI™, an ISM®<